Stock POLYG POLYGIENE GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Polygiene Group AB

Equities

POLYG

SE0007692157

Delayed Nasdaq Stockholm
Other stock markets
 06:20:54 2024-04-26 am EDT 		5-day change 1st Jan Change
9.2 SEK +0.88% Intraday chart for Polygiene Group AB +15.58% +10.18%
Apr. 25 Polygiene Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 15 Polygiene Group AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
POLYGIENE GROUP AB Stock Polygiene Group AB
+10.18% 30.55M
D+
ECOLAB INC. Stock Ecolab Inc.
+10.81% 62.84B
A-
GIVAUDAN SA Stock Givaudan SA
+12.77% 39.67B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.73B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+5.36% 18.27B
C+
CELANESE CORPORATION Stock Celanese Corporation
-0.95% 17.17B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.87% 15.81B
A-
SYMRISE AG Stock Symrise AG
-0.36% 14.96B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-20.42% 13.51B
C+
NITTO DENKO CORPORATION Stock Nitto Denko Corporation
+35.12% 12.66B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. POLYG Stock
  4. Ratings Polygiene Group AB